Policy into practice
4-5 December 2024
QEII Centre London & online
You can view the recorded content from this online conference below.
This conference is RCPath CPD accredited (10 credits).
For all enquiries, please contact Esme Carruthers.
Programme
-
SESSION ONE: Infection - what's new?
This video consists of the following presentations
-
Welcome and opening remarks
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC
-
Malaria patients with either hyper-parasitaemia or combination therapy treatment failure in the post-pandemic period: current challenges for the UK HSA Malaria Reference Laboratory
Professor Colin Sutherland, London School of Hygiene & Tropical Medicine
-
Prophylaxis as prevention of STIs - golden bullet or hostage to fortune?
Dr Helen Fifer, Consultant Microbiologist, UK Health Security Agency
-
Mpox
Dr Liz Whittaker, Imperial College London
-
Q&A
-
-
Infection: State of the Nation
Zubir Ahmed, MP for Glasgow South and PPS to Wes Streeting, Secretary of State for Health and Social Care
-
Q&A
-
SESSION THREE: Magic mushrooms! The challenge of managing invasive fungal infections
This video consists of the following presentations
-
Clinical challenges in diagnosing and treating invasive fungal infections
Dr Neil Stone, Consultant in Infectious Diseases and Microbiology, University College London Hospitals and Associate Professor, UCL
-
The changing face of fungal diagnostics
Dr Rebecca Gorton, Health Services Laboratories
-
Antifungal stewardship
Ms Laura Whitney, Regional Antimicrobial Stewardship Lead, NHSE
-
Q&A
-
SESSION FIVE: Realising the value of the specialist AMS Nursing Workforce
This video consists of the following presentations
-
Introduction
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC
-
The UK AMR NAP – implications and opportunities for AMS in nursing
Dr Lisa Ritchie, National Deputy Director for Infection Prevention and Control, NHS England
-
Role of the nurse in AMS - a view from Scotland
Mrs Jo McEwen, Lead Antimicrobial Stewardship Nurse, Ninewells Hospital
-
Role of the nurse in AMS - a view from England
Mrs Laura Ahearn RGN, Advanced Clinical Practitioner, Northern Care Alliance NHS Foundation Trust
-
Discussion
-
-
Pull incentives - securing the pipeline, improving patient outcomes
Dr Christine Årdal, Senior Scientist, Norwegian Institute of Public Health
-
Q&A
-
SESSION SEVEN: Invited papers supported by JAC and JAC-AMR
This video consists of the following presentations
-
Rapid respiratory microbiological POCTs and antibiotic use in primary care: the RAPID-TEST RCT
Dr Emily Brown, GP & NIHR Research Fellow, University of Bristol
-
Engaging health workers and the public to take action to tackle AMR: 10-years of the Antibiotic Guardian campaign
Professor Diane Ashiru-Oredope, UKHSA
-
Are proposed definitions of low-risk SAB clinically useful?
Dr Karla Berry, Internal Medical Trainee, NHS Borders
-
Use of the novel antifungal rezafungin in outpatient parenteral antibiotic therapy: early experience from a single centre
Dr Harriet Davidson, Clinical Research Fellow, City St George’s University of London
-
Q&A
-
Day One closing remarks
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC
-
SESSION EIGHT: GAMSAS - How was it for you? Experiences of accreditation from the front line
This video consists of the following presentations
-
GAMSAS – The first two years
Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor, University Hospitals of Leicester NHS Trust
-
The large teaching hospital: Imperial College London
Professor Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust
-
Lagos University Teaching Hospital
Professor Oyinlola Oduyebo, University of Lagos
-
Paediatrics: Great Ormond Street
Ms Orlagh McGarrity, Infection Pharmacist, Great Ormond Street Hospital for Children NHS Foundation Trust
-
Cancer Children's Hospital, Cairo
Mr Amr Kashef, Decision Support Senior Supervisor, Children's Cancer Hospital Egypt
-
Panel discussion
-
SESSION TEN: What else could it be? Rare, unusual and non-infections
This video consists of the following presentations
-
Paediatric case study: A captivating cavitating conundrum
Dr Gabriella Watson, Paediatric Infectious Diseases and Immunology Specialist Registrar, University Hospital Southampton
-
Is this an infection at all? Conditions that mimic infection
Dr Shrikant Ambalkar, Consultant Microbiologist, Sherwood Forest Hospitals NHS Trust
-
Therapeutic strategies for rare and imported pathogens
Dr Tommy Rampling, Consultant in infectious diseases & clinical virology, University College London Hospitals & UKHSA
-
Q&A
-
SESSION TWELVE: Focus on neonatal infections
This video consists of the following presentations
-
Impact of NICE guidance on antibiotic use in premature neonates
Dr Mike Saunders, Specialty Registrar in Public Health, East of England, UKHSA
-
Neonatal bacterial sepsis - how do we improve the outlook?
Professor Eleanor Molloy, Professor and Chair of Paediatrics, Trinity College Dublin
-
National incident response to Staphylococcus capitis in NICUs in England
Dr Alicia Demirjian, UK Health Security Agency
-
Q&A
-
SESSION THIRTEEN: Antimicrobial Susceptibility Testing - what next?
This video consists of the following presentations
-
Where are we with EUCAST ?
Dr Robin Howe, Director of Infection Services, Public Health Wales Microbiology
-
Improving MIC measurements - are newly commercial available tests the answer?
Dr Rafael Cantón, Head of the Clinical Microbiology, Hospital Universitario Ramón y Cajal, Spain
-
Innovations in molecular testing in sepsis
Professor Ignacio Martin-Loeches, Trinity College Dublin & Consultant in Intensive Care Medicine, St James's Hospital
-
Q&A
-
Closing remarks
Professor Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & President, BSAC